Skip to main content
Mimi Lee, MD, Research, San Francisco, CA

MimiCeciliaLeeMDPhD(She/Her)

Research • San Francisco, CA

Founder and Principal, Opus 132 Strategies

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lee's full profile

Already have an account?

Education & Training

  • California Institute of Integral Studies
    California Institute of Integral StudiesCertificate, Psychedelic Assisted Therapies, 2023 - 2024
  • Columbia University
    Columbia UniversityCertificate, Bioethics, 2018 - 2023
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Anesthesiology, 2001 - 2004
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Neurological Surgery, 1999 - 2000
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Surgery, 1998 - 1999
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1998
  • Harvard University
    Harvard UniversityAB, East Asian Languages and Civilizations, Cum Laude i

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2025
  • American Board of Anesthesiology Anesthesiology
  • California Institute for Integral StudiesPsychedelic-Assisted Therapies
  • Columbia UniversityBioethics

Industry Relationships

  • EVP, SamsungStrategic planning of a Gene Therapies R&D Business Unit2021 - 2022
  • VP, Novartis Institute of Biomedical ResearchGlobal Program Head for Gene Therapy assets for neurodegenerative diseases, Freidrich's Ataxia and Amyotrophic Lateral Sclerosis (SOD-1)2020 - 2022
  • Medical Director, Global Blood TherapeuticsClinical Development Lead for early development of an asset for Sickle Cell Diseases.2019 - 2020
  • Global Medical Lead, BioMarinLed global strategies for market engagement, evaluation and preparation in parallel with research and development for a gene therapy for Hemophilia A (ROCTAVIAN)/2016 - 2019
  • KOL, SonoSiteAs Co-Founder and Co-Director of Regional Anesthesia at UCSF, provided Consultant services in design and planning for interative next-generation portable ultrasound machines.2004 - 2009

External Links

Dr. Mimi Lee, Dr. Mimi Lee, MD, Dr. M Lee, Dr. Mimi Cecilia Lee